Form 4 for PLSE PULSE BIOSCIENCES, INC.
Accepted 2025-10-07 00:00:00 ET · period of report 2025-10-02 · accession 0001437749-25-030665 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-07 | 2025-10-02 | PLSE | Danahy Kevin Patrick | Chief Commercial Off | S - Sale+OE | $18.53 | -4,600 | 43.3K | -10% | -$85.2K |
| D | 2025-10-07 | 2025-10-02 | PLSE | Danahy Kevin Patrick | Chief Commercial Off | M - OptEx | $1.53 | +4,600 | 47.9K | +11% | +$7,038 |
| D | 2025-10-07 | 2025-10-02 | PLSE | Danahy Kevin Patrick | Chief Commercial Off | M - OptEx | $0.00 | -4,600 | 425.0K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-02 | S | D | 4,600 | $18.53 | 43,298 | D | — | — | (F2) The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $18.48 to $18.65 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range. |
| 2 | Common | Common Stock | 2025-10-02 | M | A | 4,600 | $1.53 | 47,898 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-10-02 | M | D | 4,600 | $0.00 | 425,000 | D | $1.53 · — to 2032-09-23 | 4,600 Common Stock | (F3) Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022. |